v3.26.1
Segment and Geographic Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Reconciliation of Segment Revenue, Measures of Segments Profit or Loss, and Significant Segment Expenses from Continuing Operations Reconciled to Consolidated Loss Before Income Taxes

The following tables reflect the reconciliation of segment revenue and significant segment expenses from continuing operations reconciled to the consolidated income (loss) from continuing operations before income taxes and equity method investments:

 

For the Three Months Ended March 31, 2026

 

 

Cannabis

 

 

Segment Totals

 

 

Other

 

 

Corporate

 

 

Total

 

Sales to external customers

$

49,744

 

 

$

49,744

 

 

$

494

 

 

$

 

 

$

50,238

 

Cost of sales

 

(28,436

)

 

 

(28,436

)

 

 

(816

)

 

 

 

 

 

(29,252

)

Selling, general and administrative expenses

 

(14,820

)

 

 

(14,820

)

 

 

(512

)

 

 

(610

)

 

 

(15,942

)

Segment operating income (loss)

$

6,488

 

 

$

6,488

 

 

$

(834

)

 

$

(610

)

 

$

5,044

 

Reconciliation of segment operating income to income from continuing operations before taxes and income from equity method investments(1)

 

Other expense, net (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

(647

)

Income from continuing operations before taxes and income from equity method investments

 

 

 

 

 

 

 

 

 

 

 

 

$

4,397

 

 

 

For the Three Months Ended March 31, 2025

 

 

Cannabis

 

 

Segment Totals

 

 

Other

 

 

Corporate

 

 

Total

 

Sales to external customers

$

39,227

 

 

$

39,227

 

 

$

453

 

 

$

 

 

$

39,680

 

Cost of sales

 

(23,958

)

 

 

(23,958

)

 

 

(1,543

)

 

 

 

 

 

(25,501

)

Selling, general and administrative expenses

 

(11,736

)

 

 

(11,736

)

 

 

(743

)

 

 

(2,140

)

 

 

(14,619

)

Segment operating income (loss)

$

3,533

 

 

$

3,533

 

 

$

(1,833

)

 

$

(2,140

)

 

$

(440

)

Reconciliation of segment operating income to loss from continuing operations before taxes and income from equity method investments(1)

 

Other expense, net (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

(688

)

Loss from continuing operations before taxes and income from equity method investments

 

 

 

 

 

 

 

 

 

 

 

 

$

(1,128

)

(1)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.
(2)
Other income (expense), net is comprised of Interest expense, interest income, foreign exchange (loss) gain, other income (expense).
(3)
Other corporate expenses are comprised of expenses related to centralized corporate functions such as accounting, treasury, information technology, legal, human services, and internal audit expenses.
Summary of Interest Income, Interest Expense, Depreciation and Amortization, Other Significant Non-Cash Items and Expenditures for Capital Assets by Reportable Segment

The following tables summarize our interest income, interest expense, depreciation and amortization, other significant noncash items, and expenditures for capital assets by reportable segment:

 

For the Three Months Ended March 31, 2026

 

Cannabis

 

Segment Totals

 

Other

 

Corporate

 

Consolidated Totals

 

 

Interest income

 

222

 

 

222

 

 

105

 

 

281

 

 

608

 

 

Interest expense

 

239

 

 

239

 

 

284

 

 

 

 

523

 

 

Depreciation and amortization

 

3,331

 

 

3,331

 

 

785

 

 

15

 

 

4,131

 

^

Share based compensation

 

77

 

 

77

 

 

 

 

299

 

 

376

 

^

Other significant noncash items:

 

 

 

 

 

 

 

 

 

 

 

Non-cash lease expense

 

190

 

 

190

 

 

 

 

54

 

 

244

 

 

Expenditures for segment assets

 

7,981

 

 

7,981

 

 

1,246

 

 

 

 

9,227

 

 

 

 

For the Three Months Ended March 31, 2025

 

Cannabis

 

Segment Totals

 

Other

 

Corporate

 

Consolidated Totals

 

 

Interest income

 

51

 

 

51

 

 

 

 

24

 

 

75

 

 

Interest expense

 

191

 

 

191

 

 

510

 

 

 

 

701

 

 

Depreciation and amortization

 

2,938

 

 

2,938

 

 

1,457

 

 

44

 

 

4,439

 

^

Share based compensation

 

48

 

 

48

 

 

13

 

 

84

 

 

145

 

^

Other significant noncash items:

 

 

 

 

 

 

 

 

 

 

 

Non-cash lease expense

 

156

 

 

156

 

 

 

 

40

 

 

196

 

 

Expenditures for segment assets

 

1,232

 

 

1,232

 

 

17

 

 

 

 

1,249

 

 

Summary of Total Assets by Reportable Segment

The following tables summarize our total assets by reportable segment:

 

 

March 31, 2026

 

 

December 31, 2025

 

Assets

 

 

 

 

 

 

Cannabis

 

$

330,926

 

 

$

335,428

 

Total assets for reportable segment

 

$

330,926

 

 

$

335,428

 

Other

 

 

49,199

 

 

 

49,038

 

Corporate

 

 

20,759

 

 

 

38,630

 

Consolidated total assets from continuing operations

 

$

400,884

 

 

$

423,096

 

Summary of Assets by Geographic Location

The Company’s primary operations are in the United States, Canada, and the Netherlands. The following tables summarizes our assets by geographic location:

Total assets from continuing operations

 

March 31, 2026

 

 

December 31, 2025

 

United States

 

$

34,021

 

 

$

36,039

 

Canada

 

 

337,811

 

 

 

363,702

 

Netherlands

 

 

29,052

 

 

 

23,355

 

 

$

400,884

 

 

$

423,096

 

 

 

 

 

 

 

 

Long-lived assets from continuing operations

 

March 31, 2026

 

 

December 31, 2025

 

United States

 

$

26,786

 

 

$

28,970

 

Canada

 

 

216,279

 

 

 

218,582

 

Netherlands

 

 

25,890

 

 

 

21,107

 

 

$

268,955

 

 

$

268,659